Ledger.Open graph →
SEC Form D · filed December 11, 2018

Khloris Biosciences, Inc

Offering
—
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Lynne A. Bui · South San Francisco, CAExec · DirectorJoseph C. Wu · South San Francisco, CADirectorJoseph C. Wu · South San Francisco, CADirectorLynne A. Bui · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗